What medications can be prescribed for a dialysis patient experiencing pruritus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Pruritus in Dialysis Patients

Start with gabapentin 100-300 mg administered after each dialysis session (three times weekly), as this is the most effective medication for uremic pruritus in hemodialysis patients. 1

Stepwise Treatment Algorithm

Step 1: Optimize Dialysis and Metabolic Parameters (Essential Foundation)

Before initiating pharmacologic therapy, address these fundamental issues:

  • Ensure adequate dialysis with a target Kt/V of approximately 1.6, as pruritus is significantly more common in underdialyzed patients 1
  • Normalize calcium-phosphate balance and control parathyroid hormone levels, as secondary and tertiary hyperparathyroidism frequently accompany end-stage renal disease and contribute to pruritus 1
  • Correct anemia with erythropoietin if present 1
  • Provide emollients as essential supportive care to address xerosis (dry skin), which is the most common cutaneous manifestation in dialysis patients and lowers the threshold for itch 2, 1

Step 2: First-Line Pharmacologic Treatment

Gabapentin is the medication of choice:

  • Dose: 100-300 mg after each dialysis session (three times weekly) 1
  • These doses are substantially lower than those used in non-ESRD populations due to reduced renal clearance 1
  • Gabapentin demonstrates the greatest reduction in itch scores among all studied interventions, with high certainty evidence 3
  • Common side effect is mild drowsiness 1

Step 3: Alternative or Adjunctive Treatments

If gabapentin is insufficient or not tolerated, consider these options:

Topical therapies:

  • Capsaicin 0.025% cream applied four times daily has shown significant efficacy, with 14 out of 17 patients reporting marked relief and 5 achieving complete remission 2, 1
  • The antipruritic effect can persist up to 8 weeks after cessation of treatment 2

Systemic alternatives:

  • Ketotifen 1 mg daily may be as effective as gabapentin but has less supporting evidence 1
  • Kappa-opioid agonists (nalfurafine) reduce itch but show a more modest effect compared to gabapentin 3

Phototherapy:

  • Broad-band UVB (BB-UVB) phototherapy is effective for many patients with uremic pruritus 1

Step 4: Short-Term Options for Severe Cases

  • Doxepin 10 mg twice daily can be used for short-term treatment, with complete resolution reported in 58% of patients versus 8% on placebo 1
  • Treatment must be limited to 8 days, 10% of body surface area, and 12 g daily 1
  • Caution is advised due to potential drowsiness 1

Critical Pitfalls to Avoid

Do NOT use these medications:

  • Cetirizine is ineffective specifically for uremic pruritus despite its use in other pruritic conditions 1, 4
  • Ondansetron has little or no effect on itch scores in dialysis patients 1, 3
  • Long-term sedative antihistamines should be avoided except in palliative care settings, as they may predispose to dementia 1, 4
  • Loratadine should be used with extreme caution in severe renal impairment 4
  • Cetirizine and levocetirizine should be avoided in severe renal impairment (creatinine clearance < 10 mL/min) 4

Important Clinical Considerations

Pruritus characteristics in dialysis patients:

  • Can be generalized (approximately 50% of cases) or localized to the back, face, or arteriovenous fistula arm 1
  • Intensity ranges from mild intermittent irritation to intractable itch that severely disrupts sleep and quality of life 1
  • May worsen during summer or at night 1
  • Some patients experience itch during or soon after dialysis treatment 1

Definitive treatment:

  • Renal transplantation is the only definitive cure for uremic pruritus but is not always feasible 1, 4

References

Guideline

Treatment for Pruritus in Chronic Kidney Disease (CKD)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Interventions for itch in people with advanced chronic kidney disease.

The Cochrane database of systematic reviews, 2020

Guideline

Antihistamine Use in End-Stage Renal Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.